Promising clinical data for fenofibrate's ability to prevent lung damage in COVID patients

(The Hebrew University of Jerusalem) In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem's Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.